6-fluoro-2-(2-hydroxy-phenyl)-3-phenethyl-3H-quinazolin-4-one

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 6-fluoro-2-(2-hydroxy-phenyl)-3-phenethyl-3H-quinazolin-4-one
• 英文别名: 6-Fluoro-2-(2-hydroxy-phenyl)-3-phenethyl-3H-quinazolin-4-one；6-fluoro-2-(2-hydroxyphenyl)-3-(2-phenylethyl)quinazolin-4-one
• 化学式: C₂₂H₁₇FN₂O₂
• 分子量: 360.388
• InChiKey: AOCHDFWZHGQOFU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.2
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.09
• 拓扑面积：
  52.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为产物：
  描述：

  2-氨基-5-氟苯甲酸 在 吡啶 作用下， 生成 6-fluoro-2-(2-hydroxy-phenyl)-3-phenethyl-3H-quinazolin-4-one
  参考文献：
  名称：

  3H-Quinazolin-4-ones as a new calcilytic template for the potential treatment of osteoporosis

  摘要：

  Structure-activity relationship studies, focused on identification of the active pharmacophore fragments in a single high-throughput screening calcilytic bit, resulted in the discovery of potent calcium receptor antagonists, substituted 3H-quinazolin-4-ones. (c) 2005 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2005.01.078

文献信息

• Quinazolinone compounds as calcilytics
  申请人：Shcherbakova Irina

  公开号：US20060052345A1

  公开（公告）日：2006-03-09

  Various calcilytic compounds and pharmaceutical compositions containing these compounds are disclosed. Calcilytic compounds are compounds capable of inhibiting calcium receptor activity. Techniques which can be used to obtain calcilytic compounds and uses of calcilyitc compounds as calcium receptor antagonists are also disclosed.

  本文揭示了各种钙离子受体抑制剂化合物及含有这些化合物的制药组合物。钙离子受体抑制剂化合物是一种能够抑制钙离子受体活性的化合物。本文还揭示了可用于获得钙离子受体抑制剂化合物的技术以及将钙离子受体抑制剂化合物用作钙离子受体拮抗剂的用途。
• EP1558260A4
  申请人：——

  公开号：EP1558260A4

  公开（公告）日：2006-10-25
• QUINAZOLINONE COMPOUNDS AS CALCILYTICS
  申请人：NPS PHARMACEUTICALS, INC.

  公开号：EP1558260A2

  公开（公告）日：2005-08-03
• [EN] QUINAZOLINONE COMPOUNDS AS CALCILYTICS<br/>[FR] COMPOSES DE QUINAZOLINONE UTILISES COMME CALCILYTIQUES
  申请人：NPS PHARMA INC

  公开号：WO2004041755A2

  公开（公告）日：2004-05-21

  Various calcilytic compounds and pharmaceutical compositions containing these compounds are disclosed. Calcilytic compounds are compounds capable of inhibiting calcium receptor activity. Techniques which can be used to obtain calcilytic compounds and uses of calcilyitc compounds as calcium receptor antagonists are also disclosed.